To validate the effect of MLPH on pancreatic cancer in vivo, we constructed a subcutaneous xenograft model using SUIT-2 cells after MLPH knockdown and overexpression (n =5/group). This evidence concerns the gene MLPH and familial pancreatic carcinoma.